Zolidon Injection 2 mg/ml contains Linezolid, a potent oxazolidinone-class antibiotic designed for intravenous administration in the treatment of serious Gram-positive bacterial infections. It is particularly useful for patients who cannot take oral medications or require rapid therapeutic levels due to the severity of their condition.
Linezolid is highly effective against multidrug-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and other Gram-positive pathogens. Zolidon Injection ensures quick systemic availability, making it suitable for hospitalized patients with complicated infections such as pneumonia, bloodstream infections, complicated skin infections, and sepsis.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Linezolid works by inhibiting bacterial protein synthesis, preventing the bacteria from multiplying:
Binds to the 50S ribosomal subunit of Gram-positive bacteria
Blocks protein synthesis, halting bacterial growth
Exhibits bacteriostatic or bactericidal effects depending on the infection type
Targets resistant strains, including MRSA and VRE
Ensures rapid and predictable plasma concentrations for effective infection control
By interfering with bacterial protein production, Zolidon Injection allows the immune system to clear the infection efficiently while controlling the spread of resistant bacteria.
Zolidon Injection 2 mg/ml is indicated for:
Hospital-acquired pneumonia (HAP) and community-acquired pneumonia (CAP) caused by Gram-positive bacteria
Complicated skin and soft tissue infections
Severe bacteremia or sepsis due to susceptible Gram-positive organisms
Vancomycin-resistant Enterococcus (VRE) infections
Cases where oral administration is not feasible or rapid systemic action is required
It is typically used in hospital settings under close medical supervision, especially for critically ill patients.
The recommended dose for adults is 600 mg intravenously every 12 hours, administered via slow IV infusion over 30–120 minutes.
Dosage may be adjusted for patients with renal or hepatic impairment.
The treatment duration depends on the severity of infection, usually ranging from 10 to 14 days, and may be extended in complicated cases.
Ensure complete therapy even if symptoms improve to prevent recurrence or development of resistance.
IV administration allows for rapid therapeutic action, making it suitable for severe infections requiring immediate intervention.
Administer under medical supervision; monitor for renal and hepatic function in prolonged therapy.
Avoid concomitant use with SSRIs, MAO inhibitors, or other serotonergic drugs due to risk of serotonin syndrome.
Monitor blood counts during extended use to detect bone marrow suppression.
Not recommended for patients with Linezolid hypersensitivity.
Avoid foods high in tyramine during treatment to prevent hypertensive crises.
Common side effects may include:
Nausea, vomiting, or diarrhea
Headache or dizziness
Mild rash or itching
Rare but serious side effects may include:
Thrombocytopenia or other hematologic abnormalities
Peripheral or optic neuropathy with long-term use
Severe allergic reactions, including swelling, difficulty breathing, or rash
Immediate medical attention is required for severe side effects such as bleeding, vision changes, or allergic reactions.
Store Zolidon Injection 2 mg/ml in a cool, dry place, away from sunlight and moisture. Keep out of reach of children. Once prepared for infusion, follow hospital protocols regarding storage and administration.
Zolidon Injection 2 mg/ml (Linezolid) is a powerful IV antibiotic for serious Gram-positive infections, providing rapid, effective therapy against resistant bacteria like MRSA and VRE under professional supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet